The jump in prescription fills comes despite limited insurance coverage and high out-of-pocket costs for Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound.
West Virginia’s Public Employee Insurance Agency is in a bind. Medical inflation continues to drive up health care costs and the PEIA finance board is looking for ways to save ...
Eli Lilly and Co.’s weight-loss drug Zepbound (tirzepatide) made headlines yet again as the Indianapolis-based firm disclosed top-line data from the Surmount-5 phase IIIb study. The open-label, ...
Engineers designed a new type of gastric balloon that can be inflated and deflated as needed. It could offer an alternative for people who don't want to undergo more invasive treatments such as ...